When does ARTELO BIOSCIENCES INC (ARTL) report earnings?
ARTELO BIOSCIENCES INC (ARTL) will report earnings on 2026-05-11.
NASDAQ:ARTL • US04301G6070
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARTELO BIOSCIENCES INC (ARTL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-19 | Maxim Group | Downgrade | Buy -> Hold |
| 2025-09-08 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2025-08-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-08 | D. Boral Capital | Upgrade | Hold -> Buy |
| 2025-06-11 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2025-06-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-01 | EF Hutton | Initiate | Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-03 | Ladenburg Thalmann | Reiterate | Buy |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 85.54% | N/A 32.79% | N/A 36.76% | N/A 11.72% | N/A 11.04% | ||||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | -2.34M | -3.21M -37.18% | -4.69M -46.11% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -20K | -30K -50.00% | -230K -666.67% | -2.34M -917.39% | -3.21M -37.18% | -4.69M -46.11% | -7.44M -58.64% | -10.29M -38.31% | -9.93M 3.50% | -10.108M -1.79% | -11.404M -12.82% | N/A -69.11% | N/A -12.07% | N/A 339.83% | N/A 140.27% | N/A 38.05% | N/A 41.51% | N/A 20.06% | N/A 11.39% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | -1.01 36.53% | -0.29 71.29% | -65.70 -22,555.17% | -57.42 12.60% | -54.90 4.39% | -41.82 23.83% | N/A 76.00% | N/A 46.34% | N/A 338.64% | N/A -101.75% | N/A 900.00% | N/A 48.30% | N/A 23.75% | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
ARTELO BIOSCIENCES INC (ARTL) will report earnings on 2026-05-11.
The consensus rating for ARTELO BIOSCIENCES INC (ARTL) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.